Showing results (1391-1400 of 1,513) with videos related to

Sort By:
Pageof 152
Oncotarget|June 1, 2017
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimenChanghoon Yoo, Jihoon Kang, Kyu-Pyo Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2017
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteriaLeena Gandhi, Sai-Hong Ignatius Ou, Alice T Shaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2025
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and ImmunotherapyConor E Steuer, Hidetoshi Hayashi, Wu-Chou Su, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 22, 2021
Economic Impact of Donating a Kidney on Living Donors: A Korean Cohort StudySehoon Park, Jina Park, Eunjeong Kang, et al.
The Oncologist|January 31, 2019
Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter StudyMinsun Jung, Soyeon Kim, June-Koo Lee, et al.
Korean Journal of Radiology|November 25, 2020
2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic RadiologySoon Ho Yoon, Sang Min Lee, Chul Hwan Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM)Sehhoon Park, Richard Baldry, Hyun Ae Jung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or LeptomeningesLaura Q M Chow, Fabrice Barlesi, Erin M Bertino, et al.
The Lancet. Respiratory Medicine|June 2, 2020
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trialYi-Long Wu, Ying Cheng, Jianying Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2017
Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung CancerJames Chih-Hsin Yang, Sai-Hong Ignatius Ou, Luigi De Petris, et al.
Pageof 152